Monoclonal Antibody of 100 µg targeting NAMPT for ELISA, IP.
| Product Specifications | |
| Application | IP, ELISA |
| Reactivity | Human |
| Clonality | Monoclonal IgG2a |
| Host | Mouse |
| Immunogen | His-tagged human NAMPT |
| Formulation | Supplied in 20mM phosphatase buffer (pH 7.5), 300mM NaCl, 50% glycerol. |
| Storage | |
| Documents & Links for Anti-NAMPT mAb (Clone: AF-1E12) | |
| Datasheet | Anti-NAMPT mAb (Clone: AF-1E12) Datasheet |
| Documents & Links for Anti-NAMPT mAb (Clone: AF-1E12) | |
| Datasheet | Anti-NAMPT mAb (Clone: AF-1E12) Datasheet |
| Citations for Anti-NAMPT mAb (Clone: AF-1E12) – 1 Found |
| Ogino, Yoko; Sato, Akira; Uchiumi, Fumiaki; Tanuma, Sei-Ichi. Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment. Oncotarget. 2018;9(23):16451-16461. PubMed - Comments: Used in: IP |